Skip to main content
Clinical Trials/NCT06589869
NCT06589869
Recruiting
Not Applicable

To Investigate the Effect of High-Intensity Focused Electromagnetic (HIFEM) Technology in the Treatment of Stress Urinary Incontinence Compared With Standard of Care in Chinese Men Who Had Undergone Robotic Radical Prostatectomy

Chinese University of Hong Kong1 site in 1 country184 target enrollmentJuly 29, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Urinary Incontinence , Stress
Sponsor
Chinese University of Hong Kong
Enrollment
184
Locations
1
Primary Endpoint
Weight of 1-hour pad test
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This is a prospective, randomized trial to evaluate the efficacy and safety of High-Intensity Focused Electromagnetic (HIFEM) Technology in the treatment of stress urinary incontinence compared with standard of care in Chinese men who had undergone robotic radical prostatectomy.

Detailed Description

This is a prospective randomised control trial of consecutive patients with prostatectomy to have either standard of care versus HIFEM assisted pelvic floor exercise. Randomization will be performed for patients when the subject has completed the informed consent for study participation. Randomization will be performed in 1:1 ratio into 2 arms: HIFEM assisted (BTL EMsella) pelvic floor muscle training (Arm A) plus Standard of care or Standard of care (Arm B).

Registry
clinicaltrials.gov
Start Date
July 29, 2022
End Date
June 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Chi Fai NG

Professor

Chinese University of Hong Kong

Eligibility Criteria

Inclusion Criteria

  • Undergone robotic radical prostatectomy
  • Able to carry out 1-hour pad test
  • Voluntary participation and signing of the informed consent form

Exclusion Criteria

  • Pre-existing stress urinary incontinence
  • Post-void residual urine greater than 200ml
  • Active urinary tract infection
  • Urethral or bladder fistula
  • History of pelvic irradiation
  • Neurological condition (Spinal cord problems, stroke with poor neurological recovery, epilepsy, Parkinson disease, multiple sclerosis)
  • Previous surgery for SUI
  • Concurrent medication with diuretics, serotonin-norepinephrine reuptake inhibitors or any other medication known to worsen incontinence
  • Condition contraindicated for electromagnetic therapy i.e. Arrhythmia, on a pacemaker or implanted metallic device; Coagulopathy or on anticoagulant

Outcomes

Primary Outcomes

Weight of 1-hour pad test

Time Frame: Baseline, Month 1, Month 3 and Month 6

Weight of 1-hour pad test

Secondary Outcomes

  • Severity of Incontinence.(Baseline, Month 1, Month 3 and Month 6)
  • Sexual Function(Baseline, Month 1, Month 3 and Month 6)
  • Severity of Incontinence(Baseline, Month 1, Month 3 and Month 6)
  • Complications(Month 1, Month 3 and Month 6)

Study Sites (1)

Loading locations...

Similar Trials